Anidulafungin: all 28 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Negative Beta Glucan in ICU PatientsCompletedNCT01734525Phase 4Results posted
- Effect of Weight and/or Obesity on Anidulafungin Drug ConcentrationsCompletedNCT01307930Phase 4Results posted
- A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive CandidiasisTerminatedNCT01176058Phase 3Results posted
- A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy SubjectsCompletedNCT00940017Phase 4Results posted
- Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal TreatmentTerminatedNCT00934934Phase 2Results posted
- Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant RecipientsCompletedNCT00841971Phase 4Results posted
- Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive CandidiasisCompletedNCT00761267Phase 3Results posted
- Anidulafungin PK in Infants and ToddlersCompletedNCT00734500Phase 1Results posted
- Anidulafungin Candidemia/Invasive Candidiasis Intensive Care StudyCompletedNCT00689338Phase 3Results posted
- β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) PatientsCompletedNCT00672841Not applicableResults posted
- Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)TerminatedNCT00620074Phase 4Results posted
- This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive CandidiasisCompletedNCT00548262Phase 4Results posted
- Anidulafungin In Treatment Of Candidemia In Asian SubjectsCompletedNCT00537329Phase 3Results posted
- Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive AspergillosisCompletedNCT00531479Phase 3Results posted
- Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive CandidiasisCompletedNCT00496197Phase 4Results posted
- Anidulafungin Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ADOPT)CompletedNCT02021123Phase 4
- Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant RecipientsCompletedNCT01303549Phase 4
- Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal DiseaseCompletedNCT01249820Phase 2
- Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric SubjectsWithdrawnNCT01188759Phase 3
- Anidulafungin in Patients With Hematologic MalignanciesTerminatedNCT01053884Phase 2
- Anidulafungin During Continuous Venovenous Hemofiltration (CVVHF)Status unknownNCT00892359Phase 2
- Anidulafungin in Treating Immunocompromised Children With NeutropeniaCompletedNCT00068471Phase 1/2
- Anidulafungin Versus Fluconazole in the Treatment of CandidemiaCompletedNCT00058682Phase 3
- Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17CompletedNCT00056381Phase 1/2
- The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive CandidiasisCompletedNCT00056368Phase 3
- The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC)CompletedNCT00041704Phase 2
- The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.CompletedNCT00037219Phase 2
- A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).CompletedNCT00037206Phase 2/3